Comparison of CWD and ICW tympanomastoidectomy with endoscopic control to evaluate residual cholesteatoma for patients with middle and mastoid cholesteatoma

Comparison of residual cholesteatoma in two methods of tympanomastoidectomy CWD and ICW with endoscopic control in patients with middle ear and mastoid cholesteatoma

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191123045472N1

Enrollment

Registered

2020-07-13

Start date

2011-04-04

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tympanomastoidectomy in people with cholesteatoma. Cholesteatoma of middle ear

Interventions

Intervention 1: "Intervention group": Twenty patients with cholesteatoma in the intervention group underwent CWD (tympanomastoidectomy with posterior wall resection) without chain reconstruction. Post

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed with microscopic examination of cholesteatoma and who were candidates for surgery, with any hearing loss

Exclusion criteria

Exclusion criteria: Patient with cholesteatoma with posterior wall destruction The patient does not follow-up or postoperative follow-up examinations for any reason. The patient has complications of cholesteatoma, such as dizziness, facial paralysis, sensorineural hearing loss average or above average, intracranial complications, mastoid abscess, lateral sinus thrombosis, etc The patient should be treated with revision Failure after graft surgery

Design outcomes

Primary

Measure	Time frame
The amount of remaining cholesteatoma. Timepoint: 3 months, 6 months, 9 months and 12 months. Method of measurement: Endoscope 30 ° and 7.2 mm.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Pedram Borghei

Tehran University of Medical Sciences

entrc.tums@gmail.com+98 21 6634 9253

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026